Venrock Healthcare Capital Partners III, L.P.
Disclosed holdings of Venrock Healthcare Capital Partners III, L.P. as of 2025-02-14: 4.15M shares of Oruka Therapeutics (ORKA), worth about $397M at the last…
What Venrock Healthcare Capital Partners III, L.P. reported holding
As of the latest filing on , Venrock Healthcare Capital Partners III, L.P. reported holding 4,148,428 shares of Oruka Therapeutics (ORKA), worth about $397M at the last close of $96 (Oct 27, 2026), held through a funds. Holdings are also on file at Lycia Therapeutics (LYCA); together they are worth about $576M. In the last 12 months, Venrock Healthcare Capital Partners III, L.P. bought $37.7M in 6 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Oruka Therapeutics ORKA | 4,148,428 | 4.15M funds | $96 | $397M | Feb 14, 2025 |
| Lycia Therapeutics LYCA | 6,825,233 | 6.83M funds | $26 | $178M | Oct 27, 2026 |
Is this Venrock Healthcare Capital Partners III, L.P.’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Insider buying and selling since 2020
Venrock Healthcare Capital Partners III, L.P. bought shares on the open market in 2020, 2025 and 2026 across 3 companies.
Venrock Healthcare Capital Partners III, L.P. reported 14 open-market purchases and 0 sales since 2020; purchases in 3 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 6×6 trades | — |
| 2025 | 5×5 trades | — |
| 2020 | 3×3 trades | — |
Insider at 3 companies
- Lycia Therapeutics LYCA2026 · 6 purchases, 0 sales
- Oruka Therapeutics ORKA2025 · 5 purchases, 0 sales
- Cogent Biosciences COGT2020 · 3 purchases, 0 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The companies behind these filings
- Lycia Therapeutics LYCA
Venrock Healthcare Capital Partners III, L.P. reported 6 open-market purchases and 0 sales here, 2026.
- Last close
- $26.11
- Oruka Therapeutics ORKA
Venrock Healthcare Capital Partners III, L.P. reported 5 open-market purchases and 0 sales here, 2025.
- Market value
- $6.34B
- Last close
- $95.81
- 12 months
- +245.9%
- Against the S&P 500
- +233.6 pts
- Revenue (last year)
- $0
- Cogent Biosciences COGT
Venrock Healthcare Capital Partners III, L.P. reported 3 open-market purchases and 0 sales here, 2020.
- Market value
- $5.55B
- Last close
- $32.01
- 12 months
- +97.6%
- Against the S&P 500
- +85.3 pts
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Free account: get the written context of this page. Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Venrock Healthcare Capital Partners III, L.P.'s trades
Has Venrock Healthcare Capital Partners III, L.P. bought shares on the open market?
Venrock Healthcare Capital Partners III, L.P. bought shares on the open market in 2020, 2025 and 2026 across 3 companies.
When did Venrock Healthcare Capital Partners III, L.P. last buy or sell shares?
In SEC filings since 2020: the latest open-market purchase is from 2026; no open-market sale is on record.
Which companies has Venrock Healthcare Capital Partners III, L.P. traded as an insider?
3 companies: Lycia Therapeutics (LYCA, 2026), Oruka Therapeutics (ORKA, 2025), Cogent Biosciences (COGT, 2020).